A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus
Clinical trial NCT06362265 · COMPLETED
Trial details
- NCT number
- NCT06362265
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-10
- Primary completion
- 2026-01-02
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.